Fintel reports that on January 8, 2025, TD Cowen downgraded their outlook for Leidos Holdings (NYSE:LDOS) from Buy to Hold.

Leidos (LDOS) ended the recent trading session at $145.75, demonstrating a -1.05% swing from the preceding day's closing price. This change lagged the S&P 500's daily gain of 0.16%. Meanwhile, the Dow ...

Analysts have recently evaluated Leidos Holdings and provided 12-month price targets. The average target is $198.57, ...

Leidos Holdings (LDOS – Research Report) received a Hold rating and a $165.00 price target from TD Cowen analyst Gautam Khanna today. The ...

This was the stock's second consecutive day of losses.

Wells Fargo lowered the firm’s price target on Leidos (LDOS) to $199 from $205 and keeps an Overweight rating on the shares. The firm’s ...

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the brand name Leidos QTC Health Services, has been awarded a contract by the Veterans ...

GAMMA Investing LLC boosted its holdings in Leidos Holdings, Inc. (NYSE:LDOS – Free Report) by 32.2% during the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,515 ...

Shares of Leidos Holdings Inc. LDOS slipped 0.63% to $147.30 Tuesday, on what proved to be an all-around grim trading session ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...